Skip to content
OpenCapital
Get started

Aura Biosciences, Inc. AURA Q4 2024 Annual earnings

Reported March 24, 2025 · Before market open

EPS-$0.52Miss by $0.09
EPS estimate-$0.43

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.41

Financials

Q4 2024

Income statement

See full
Operating income-$27.8M-12.2%
Net income-$25.8M-16.7%
EPS (diluted)-$0.52-4.0%

Balance sheet

See full
Cash & equivalents$31.7M-22.8%
Total debt$18.8M-4.0%
Total equity$152.0M-32.7%
Total assets$182.5M-28.5%

Cash flow

See full
Operating cash flow-$24.0M-37.8%
CapEx$299.0K-5.7%
Free cash flow-$24.3M-37.0%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$410.6M-5.9%
Enterprise value$397.68M-4.2%

Returns & leverage

See full
Return on equity-46%+16.9pp
Debt / equity0.1×0.0×
Current ratio10.8×-8.0×

Versus estimates

Diluted EPS

Q1 2026-$0.50Miss by $0.10Q4 2025-$0.37Beat by $0.06Q3 2025-$0.40Beat by $0.06Q2 2025-$0.47Beat by $0.02Q1 2025-$0.55Miss by $0.08
Q4 2024-$0.52Miss by $0.09

Ask the moment Aura Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aura Biosciences, Inc. report Q4 2024 earnings?
Aura Biosciences, Inc. (AURA) reported Q4 2024 earnings on March 24, 2025 before market open.
What were Aura Biosciences, Inc.'s Q4 2024 revenue and EPS?
Aura Biosciences, Inc. reported eps of $-0.52 for Q4 2024.
Did Aura Biosciences, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.43 by $0.09.
Where can I find Aura Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-043943) directly on SEC EDGAR. The filing index links above go to sec.gov.